Pure Global
NCT05721118

Diagnostic Performances of Mandibular CBCT in Osteoporosis

Diagnostic Performances of Mandibular CBCT Versus DXA Gold-Standard in Bone Mineral Density Assessment and Osteoporosis Diagnosis.
Nantes University Hospital·ClinicalTrials.gov·diagnostic testNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Osteoporosis
Drug/Device/Intervention
CBCT and DXA exams performed in current practice in Nantes University Hospital
Study type
Observational
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
Nantes University Hospital
Timeline & enrollment
Phase
N/A
Start date
Mar 08, 2023
End date
Mar 10, 2023
Enrollment
40 participants
Primary outcome

Assessment of diagnostic performances of CBCT multivariate explicative model of osteoporosis regarding DXA T-Score Gold-Standard (-2,5DS).

Summary

In the last decade, there has been a shift towards Cone-Beam Computed Tomography (CBCT -
 regarding its low-dose radiation profile) in Dentistry/Implantology fields because it
 presents a more conclusive insight in the bone micro-architecture and cortical/trabecular
 bone structures assessment due to 3D acquisition higher resolution. Despite convergent and
 interesting preliminary results, most CBCT studies failed in highlighting a potential new
 osteoporosis diagnostic tool. TOMOSTEOp study aims to explore inter-relation between CBCT
 parameters and DXA Gold-Standard parameters in order to build resolutive explicative model of
 bone mineral density and test CBCT diagnostic performances.

ICD-10 classifications
Osteoporosis, unspecifiedOther osteoporosisIdiopathic osteoporosisOsteoporosis in diseases classified elsewherePostmenopausal osteoporosis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05721118
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05721118 through Pure Global AI's free database. This phase not specified trial is sponsored by Nantes University Hospital and is currently Not yet recruiting. The study focuses on Osteoporosis. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.